Teladoc (TDOC) PT Raised to $262 at Cowen to Include Livongo Health

Cowen analyst Charles Rhyee raised the price target on Teladoc (NYSE: TDOC) to $262.00 (from $250.00) to include the Livongo Health (NASDAQ: LVGO) acquisition

The analyst maintained an Outperform rating, stating "We expect proforma rev will grow at~40% CAGR thru 2023, at the high-end of mgmt's pre-synergy forecast. We think the LVGO merger is an opportunity for TDOC to re-imagine healthcare delivery & build on the substantial uptake in telehealth/virtual care. Current valuation of ~11x our 2022 proforma rev is an attractive entry point, in our view".

You May Also Be Interested In

• Teladoc (TDOC) PT Lowered to $8 at Truist Securities
• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Sansera Engineering Ltd (SANSERA:IN) PT Raised to INR4,250 at ICICI Securities